<--- Back to Details
First PageDocument Content
Biology / Molecular biology / Biotechnology / Nature / Hoffmann-La Roche / Genentech / South San Francisco /  California / Tissue plasminogen activator / Recombinant DNA / Polymerase chain reaction / Growth hormone treatment / Trastuzumab
Date: 2005-08-06 16:58:13
Biology
Molecular biology
Biotechnology
Nature
Hoffmann-La Roche
Genentech
South San Francisco
California
Tissue plasminogen activator
Recombinant DNA
Polymerase chain reaction
Growth hormone treatment
Trastuzumab

Digital Unix 4.0 Upgrade Plan

Add to Reading List

Source URL: www.cgl.ucsf.edu

Download Document from Source Website

File Size: 381,87 KB

Share Document on Facebook

Similar Documents

The First Reported Case of Acute Ischemic Stroke Treated with Tissue Plasminogen Activator at Mansoura University, Egypt

DocID: 1ukhu - View Document

tPA - roles tPA - inhibitors Tissue plasminogen activator (tPA)

DocID: 1rEhZ - View Document

Medicine / Medical terminology / RTT / Stroke / Tissue plasminogen activator / National Institutes of Health Stroke Scale / CT scan / Patient

TimeSpan: Using Visualization to Explore Temporal Multi-dimensional Data of Stroke Patients Mona Hosseinkhani Loorak, Charles Perin, Noreen Kamal, Michael Hill, and Sheelagh Carpendale Abstract— We present TimeSpan, an

DocID: 1rhho - View Document

Angiology / RTT / Stroke / Reperfusion injury / Ischemia / Natural gas / Tissue plasminogen activator / Medicine / Anatomy

■ VeriTran, Inc. is commercializing a patented Infinitely Variable Transmission (IVT) which allows variable pumping rates for optimizing production in oil field pump jacks. Installations to date validate production in

DocID: 1qYRk - View Document

Angiology / RTT / Stroke / Reperfusion injury / Ischemia / Natural gas / Tissue plasminogen activator / Medicine / Anatomy

■ VeriTran, Inc. is commercializing a patented Infinitely Variable Transmission (IVT) which allows variable pumping rates for optimizing production in oil field pump jacks. Installations to date validate production in

DocID: 1qOwp - View Document